Company profileMixed portfolio#186 of 1,318 in Pakistan✓ No DRAP alerts

Solaris Life Sciences Private Limited, DML: 000992

Mixed portfolio · 30 pharmaceutical brands of 95 registrations

95 registered products 30 pharmaceutical brands 24 distinct molecules 0 DRAP alerts
Part of this company's portfolio (“Nutritional Supplement / Multivitamin”) is registered under a broad DRAP category rather than distinct molecules, so the molecule count understates its true range.

Company overview

95
registered products
30
pharmaceutical brands
24
distinct molecules
0
therapeutic classes
0
DRAP alerts

Solaris Life Sciences Private Limited, DML: 000992 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 95 product registrations across 24 distinct molecules. It is the 186th largest registrant in Pakistan by product count. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Solaris

8 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

6
ceilings with an approval date
1
not revised in 2+ years
2024
oldest approval year
20241
20265
Longest without revision

Top molecules by brand count

Nutritional Supplement / Multivitamin53 brands
Deferasirox4 brands
Sodium3 brands
Tacrolimus3 brands
Ceftriaxone3 brands
Cefixime3 brands
Amlodipine2 brands
Azithromycin2 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official3 products · Rs 113.42 – Rs 591.98
DVAGO2 products · Rs 270.75 – Rs 1,515.3
Median across source: Rs 893.02

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Pharmasol (Pvt) Ltd. holds 111 molecules not in this portfolio
AcetazolamideAcyclovirAlpha KetoanaloguesAnastrazoleAnastrozoleAprepitant
Global Pharmaceuticals Pakistan holds 140 molecules not in this portfolio
AmikacinAmlodipineAmocycillinAmoxicillinAmoxicillin AmoxicillintrihydrateAmoxycillin
BIO LABS (PVT) LTD. holds 134 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate

Get the full profile for Solaris

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.